Major Indexes

My Watchlist Items

4D pharma plc (LBPS)
   10.59   -0.41(-3.73%)
4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease. It also develops immuno-oncology products comprising MRx0518, MRx0573, and MRx1299 for solid tumors, and MRx0518 for pancreatic cancer; respiratory products, such as MRx-4DP0004 for asthma and COVID-19; central nervous system products, including MRx0005 and MRx0029 for neurodegeneration; and platform products comprising vaccines and autoimmune. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumours. The company was formerly known as Schosween 18 Limited. 4D pharma plc was founded in 2014 and is headquartered in Leeds, the United Kingdom.
TitleNamePayCurrency PayGenderYear BornTitle Since
Chief Medical Officer Dr. John D. Weinberg N/A USD N/A N/A
Gen. Counsel & Company Sec. Mr. Laurence Dale N/A USD male N/A N/A
Head of Investor Relations Fay Weston N/A USD N/A N/A
Chief Financial Officer Mr. John W. Beck CPA, CPA N/A USD male N/A N/A
Chief Scientific Officer & Executive Director Dr. Alexander James Stevenson 141370 USD 1972 N/A
Chief Executive Officer & Executive Director Mr. Duncan Joseph Peyton 141370 USD male 1970 N/A
SymbolDateRatingRating Score Rating Details
HolderSharesDate ReportedChange
HolderSharesDate ReportedWeight Percent
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
SymbolDatePeriodDownload XLSX File
LBPS 2021 FY Download XLSX File
LBPS 2020 FY Download XLSX File
LBPS 2021 Q2 Download XLSX File
LBPS 2020 Q4 Download XLSX File


Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated

Company Profile

Company Name 4D pharma plc
Symbol LBPS
Currency USD
Price 10.59
Exchange Name Nasdaq Global Select (NASDAQ)
Industry Biotechnology
CEO Mr. Duncan Joseph Peyton
Sector Healthcare
Country GB
Full Time Employees 92
Address 9 Bond Court
City Leeds